Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB

Neurology

Volumn 66, Issue 6, 2006, Pages 935-937

  Mori, T ^a   Ikeda, M ^a   Fukuhara, R ^a   Nestor, P J ^b   Tanabe, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

AGED; ARTICLE; ASSOCIATION CORTEX; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEMENTIA WITH LEWY BODY; DIAGNOSTIC IMAGING; DIFFUSE LEWY BODY DISEASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; NEUROIMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; VISUAL CORTEX; VISUAL HALLUCINATION; BLOOD FLOW; BRAIN CIRCULATION; COMPARATIVE STUDY; HALLUCINATION; OCCIPITAL LOBE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR CIRCULATION; FEMALE; HALLUCINATIONS; HUMANS; INDANS; LEWY BODY DISEASE; MALE; OCCIPITAL LOBE; PIPERIDINES; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33645834092     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000203114.03976.b0     Document Type: Article

References (10)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
2. McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-2036.
3. Ishii K, Imamura T, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998;51:125-130.
4. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-649.
5. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatrie Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
6. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999;7:254-266.
7. Imamura T, Ishii K, Hirono N, et al. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 1999;10:1903-1907.
8. Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 1993;7:69-79.
9. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994;5:747-749.
10. Middelkoop HA, van der Flier WM, Burton EJ, et al. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology 2001;57:2117-2120.